Have your own idea? Try our Stock Screener
Egyptian (CASE/EGX) Healthcare Sector Analysis
UpdatedMar 13, 2025
DataAggregated Company Financials
Companies16
- 7D3.8%
- 3M8.2%
- 1Y34.7%
- YTD9.5%
In the last week, the Healthcare industry is up 3.8%, with Ibnsina Pharma up 13%. This means that the industry has gained 35% over the past year. Earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Egyptian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 13 Mar 2025 | ج.م52.3b | ج.م87.7b | ج.م4.0b | 9.5x | 13.2x | 0.6x |
| Sat, 08 Feb 2025 | ج.م48.1b | ج.م78.0b | ج.م3.4b | 17.6x | 14.3x | 0.6x |
| Mon, 06 Jan 2025 | ج.م48.6b | ج.م77.9b | ج.م3.4b | 18.9x | 14.5x | 0.6x |
| Wed, 04 Dec 2024 | ج.م46.5b | ج.م76.9b | ج.م3.1b | 17.9x | 14.8x | 0.6x |
| Fri, 01 Nov 2024 | ج.م45.7b | ج.م69.2b | ج.م2.9b | 9.1x | 15.8x | 0.7x |
| Sun, 29 Sep 2024 | ج.م42.4b | ج.م69.3b | ج.م2.9b | 10.1x | 14.8x | 0.6x |
| Tue, 27 Aug 2024 | ج.م35.1b | ج.م68.9b | ج.م3.1b | 7.9x | 11.3x | 0.5x |
| Thu, 25 Jul 2024 | ج.م34.6b | ج.م63.7b | ج.م3.1b | 7.6x | 11.3x | 0.5x |
| Sat, 22 Jun 2024 | ج.م33.7b | ج.م63.2b | ج.م3.0b | 8.4x | 11.3x | 0.5x |
| Mon, 20 May 2024 | ج.م33.1b | ج.م58.3b | ج.م2.4b | 11.6x | 13.7x | 0.6x |
| Wed, 17 Apr 2024 | ج.م36.5b | ج.م57.5b | ج.م2.4b | 12.4x | 15.5x | 0.6x |
| Fri, 15 Mar 2024 | ج.م37.1b | ج.م56.8b | ج.م2.8b | 10.5x | 13.1x | 0.7x |
| Sun, 11 Feb 2024 | ج.م36.4b | ج.م52.6b | ج.م3.0b | 10.5x | 12.1x | 0.7x |
| Tue, 09 Jan 2024 | ج.م33.0b | ج.م50.2b | ج.م2.8b | 9.7x | 11.9x | 0.7x |
| Thu, 07 Dec 2023 | ج.م34.5b | ج.م44.1b | ج.م2.7b | 12.4x | 12.7x | 0.8x |
| Sat, 04 Nov 2023 | ج.م27.4b | ج.م45.6b | ج.م2.5b | 10.3x | 10.9x | 0.6x |
| Mon, 02 Oct 2023 | ج.م24.9b | ج.م45.5b | ج.م2.5b | 9.5x | 10x | 0.5x |
| Wed, 30 Aug 2023 | ج.م24.9b | ج.م45.8b | ج.م2.6b | 9.9x | 9.5x | 0.5x |
| Fri, 28 Jul 2023 | ج.م24.7b | ج.م42.7b | ج.م2.6b | 9.8x | 9.5x | 0.6x |
| Sun, 25 Jun 2023 | ج.م26.1b | ج.م43.1b | ج.م2.7b | 9.2x | 9.7x | 0.6x |
| Tue, 23 May 2023 | ج.م26.1b | ج.م41.6b | ج.م2.9b | 9x | 9.1x | 0.6x |
| Thu, 20 Apr 2023 | ج.م25.5b | ج.م41.6b | ج.م2.9b | 8.5x | 8.8x | 0.6x |
| Sat, 18 Mar 2023 | ج.م23.4b | ج.م41.0b | ج.م2.8b | 7.7x | 8.4x | 0.6x |
| Mon, 13 Feb 2023 | ج.م27.7b | ج.م40.5b | ج.م2.8b | 10x | 9.8x | 0.7x |
| Wed, 11 Jan 2023 | ج.م27.1b | ج.م40.4b | ج.م2.8b | 10x | 9.6x | 0.7x |
| Fri, 09 Dec 2022 | ج.م27.2b | ج.م40.4b | ج.م2.9b | 8x | 9.3x | 0.7x |
| Sun, 06 Nov 2022 | ج.م23.2b | ج.م40.0b | ج.م2.8b | 7.5x | 8.3x | 0.6x |
| Tue, 04 Oct 2022 | ج.م22.7b | ج.م40.0b | ج.م2.8b | 7.7x | 8.1x | 0.6x |
| Thu, 01 Sep 2022 | ج.م23.6b | ج.م39.2b | ج.م2.7b | 8.2x | 8.8x | 0.6x |
| Sat, 30 Jul 2022 | ج.م23.1b | ج.م39.5b | ج.م2.6b | 7x | 8.8x | 0.6x |
| Mon, 27 Jun 2022 | ج.م23.8b | ج.م39.5b | ج.م2.6b | 7x | 9.1x | 0.6x |
| Wed, 25 May 2022 | ج.م25.3b | ج.م36.7b | ج.م2.4b | 7.2x | 10.7x | 0.7x |
| Fri, 22 Apr 2022 | ج.م26.1b | ج.م36.6b | ج.م2.3b | 7.3x | 11.1x | 0.7x |
| Sun, 20 Mar 2022 | ج.م25.6b | ج.م37.5b | ج.م2.5b | 9.4x | 10.3x | 0.7x |
Price to Earnings Ratio
10.3x
Current Industry PE
- Investors are optimistic on the Egyptian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 13.2x which is higher than its 3-year average PE of 11.1x.
- The industry is trading close to its 3-year average PS ratio of 0.62x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 17% per year over the last three years.
- Revenues for these companies have grown 33% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Egyptian Healthcare sector?
| EG Market | 0.48% | |
| Healthcare | 3.76% | |
| Pharma | 4.62% | |
| Healthcare Services | 2.79% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry, which is trading close to its 3-year average PE ratio of 22.3x.
- Analysts are expecting annual earnings growth of 25.2%, which is lower than the prior year's growth of 125.8% per year.
- Investors are most pessimistic about the Pharma industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 7.8x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 25% over the next 5 years.
- However this is lower than its past earnings growth rate of 126% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 24% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ISPH Ibnsina Pharma | ج.م7.57 | 13.0% +ج.م877.0m | 164.7% | PE15.3x | |
| MPCI Memphis Pharmaceuticals & Chemical Industries | ج.م80.95 | 34.6% +ج.م473.0m | -19.3% | PE4.9x | |
| PHAR Egyptian International Pharmaceutical Industries | ج.م50.00 | 3.1% +ج.م223.1m | 2.3% | PE6.8x | |
| RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E | ج.م4.43 | 3.3% +ج.م210.5m | 69.1% | PE17.2x | |
| BIOC GlaxoSmithKlineE | ج.م38.82 | 4.9% +ج.م152.0m | 17.1% | PE18.6x |